Middle East and Africa Breast Reconstruction Market is expected to grow with the CAGR of 6.6% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below:

Access Full Report @ https://www.databridgemarketresearch.com/reports/middle-east-and-africa-breast-reconstruction-market

Middle East & Africa breast reconstruction market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in Middle East & Africa breast reconstruction market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio. For instance, in March 2019, Johnson & Johnson Services, Inc. announced that the company received Food and Drug Administration (FDA) approval for their MemoryShape device under Premarket Approval (PMA) Application. This will help the company in expanding their portfolio in the breast reconstruction implant market.

Johnson & Johnson Services, Inc. is dominating player in Middle East & Africa breast reconstruction market. The other key players existing in the market includes POLYTECH Health & Aesthetics GmbH, CEREPLAS, Guangzhou Wanhe Plastic Materials Co., Ltd, ALLERGAN, GC Aesthetics, Laboratories Arion, Sientra, Inc. and HANSBIOMED CO. LTD among others.

Johnson & Johnson Services, Inc.

Johnson & Johnson Services, Inc. is headquartered in New Jersey, U.S was founded in 1886. The company is engaged in the research and development, manufacturing and sale of the wide range of products in the health care field. The company has multiple business segments which are pharmaceutical, medical devices, consumer, out of which medical devices is market focused segment. The company provides products in various categories such as mentor, depuy synthes, ethicon, out of these mentor is the market focused category.

• In March 2019, Johnson & Johnson Services, Inc. announced that the company received Food and Drug Administration (FDA) approval for their MemoryShape device under Premarket Approval (PMA) Application. This will help the company in expanding their portfolio in the breast reconstruction implant market

The company has presence in Europe, North America, Asia-Pacific, Middle East & Africa, South America. The company has various subsidiaries such as Janssen Pharmaceutica (Belgium), Neutrogena (U.S.), DePuy Synthes Companies (U.S.), Ethicon Inc. (U.S.), Actelion (Switzerland) among others.

Allergan

Allergan is headquartered in Dublin, Ireland and was founded in 1983. The company focuses on manufacturing, developing and commercializing branded device, biologic, pharmaceutical, surgical and regenerative medicine products for patients. The company deals in multiple segments such as US specialized therapeutics, US general medicine, international, other, out of this US specialized therapeutics is the market focused segment. The company provide their product in multiple categories such as labeling, vermont out of which labeling is the market focused category.

• In February 2017, Allergan announced that they have acquired LifeCell Corporation for approximately USD 2.9 billion in cash, which is a leading regenerative medicine company. After this acquisition with the combination of LifeCell's novel regenerative medicine products, the company is globally offering more products for plastic surgeons

The company has wide global presence across North America, South America, Europe, Asia, Middle East and Africa with their subsidiaries such as ZELTIQ Aesthetics, Inc. (U.S.), Bonti, Inc. (U.S.), Allergan Medical (U.S.), Kythera Biopharmaceuticals, Inc. (U.S.), Oculeve, Inc. (U.S.) among others.

Sientra, Inc.

Sientra, Inc. is headquartered in California, U.S. and was founded in 2003. The company focus on providing true artists with the best tools which give optimal results; their best of breast products are exclusive to most skilled plastic surgeons. The company has multiple business segments which are miradry, breast products, out of which breast products is market focused segment. The company provides products in various categories such as M breast implants, breast tissue expanders, silicone scar treatment, additional tissue expanders, mammary implants, out of these breast implants, breast tissue expanders, mammary are the market focused category.

• In July 2017, Sientra, Inc. announced that they acquire Miramar Labs, Inc. (U.S), this acquisition will widen the aesthetics portfolio related to the breast reconstruction market.

The company has presence in North America, Europe, Asia-Pacific, South America, Middle East and Africa. The company has various subsidiaries such as Desert Acquisition Corporation (U.S.), miraDry Holdings (U.S.), Inc, Silimed, Inc. (U.S.), Miramar Labs Inc. (U.S.), among others.